Free Trial

Genpact Limited (NYSE:G) Shares Acquired by Lazard Asset Management LLC

Genpact logo with Business Services background

Lazard Asset Management LLC increased its position in shares of Genpact Limited (NYSE:G - Free Report) by 115.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 80,319 shares of the business services provider's stock after buying an additional 43,011 shares during the period. Lazard Asset Management LLC's holdings in Genpact were worth $3,448,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in G. Wedge Capital Management L L P NC boosted its holdings in Genpact by 6.5% during the fourth quarter. Wedge Capital Management L L P NC now owns 46,179 shares of the business services provider's stock worth $1,983,000 after buying an additional 2,830 shares in the last quarter. HB Wealth Management LLC lifted its holdings in Genpact by 18.9% during the fourth quarter. HB Wealth Management LLC now owns 10,224 shares of the business services provider's stock valued at $439,000 after purchasing an additional 1,627 shares in the last quarter. Kera Capital Partners Inc. purchased a new position in Genpact during the fourth quarter valued at $268,000. Aaron Wealth Advisors LLC lifted its holdings in Genpact by 8.0% during the fourth quarter. Aaron Wealth Advisors LLC now owns 7,437 shares of the business services provider's stock valued at $319,000 after purchasing an additional 548 shares in the last quarter. Finally, UMB Bank n.a. lifted its holdings in Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock valued at $52,000 after purchasing an additional 433 shares in the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Genpact

In related news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. This trade represents a 4.20% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Nicholas C. Gangestad acquired 2,000 shares of the business's stock in a transaction that occurred on Tuesday, May 13th. The shares were purchased at an average price of $43.97 per share, with a total value of $87,940.00. Following the completion of the transaction, the director now owns 2,000 shares of the company's stock, valued at $87,940. The trade was a ∞ increase in their position. The disclosure for this purchase can be found here. Insiders own 3.07% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and increased their price objective for the company from $45.00 to $60.00 in a report on Friday, February 7th. Needham & Company LLC decreased their price objective on shares of Genpact from $55.00 to $50.00 and set a "buy" rating on the stock in a report on Thursday, May 8th. Mizuho increased their price objective on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Finally, Robert W. Baird decreased their price objective on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a report on Thursday, May 8th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $50.71.

Check Out Our Latest Research Report on G

Genpact Price Performance

Shares of NYSE:G traded down $0.17 during midday trading on Thursday, hitting $43.50. The company's stock had a trading volume of 202,132 shares, compared to its average volume of 1,364,475. The business's 50 day simple moving average is $47.69 and its 200 day simple moving average is $47.25. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. The company has a market cap of $7.61 billion, a P/E ratio of 15.32, a price-to-earnings-growth ratio of 1.84 and a beta of 1.02. Genpact Limited has a 12-month low of $30.38 and a 12-month high of $56.76.

Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.04. The firm had revenue of $1.21 billion for the quarter, compared to the consensus estimate of $1.21 billion. Genpact had a net margin of 10.77% and a return on equity of 22.50%. The company's revenue for the quarter was up 7.4% on a year-over-year basis. During the same period last year, the firm posted $0.73 earnings per share. On average, analysts forecast that Genpact Limited will post 3.21 EPS for the current year.

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

See Also

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines